Related Experiment Video
Updated: Feb 23, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.4K
Interventions to Improve Adherence to a Hypoglycemia Protocol.
Lani Destree1, Mary Vercellino1, Nancy Armstrong2
1Edward Hospital, Clinical Education, Naperville, IL.
Summary
Using timers significantly improved hospital staff adherence to hypoglycemia protocols, ensuring timely blood glucose rechecks after treatment. This efficient method supports better patient blood glucose management.
Area of Science:
- Clinical Nursing
- Hospital Management
- Patient Safety
Background:
- A hospital implemented an evidence-based hypoglycemia protocol to manage blood glucose levels.
- Low adherence to the protocol's 15-minute blood glucose recheck after treatment was observed.
- Previous interventions like education and reference cards failed to improve compliance.
Purpose of the Study:
- To compare two interventions for improving adherence to hypoglycemia treatment protocols.
- To enhance the timely rechecking of blood glucose levels after hypoglycemia treatment.
Main Methods:
- A pilot study compared two interventions: PCTs staying with patients vs. using timers.
- Patient care technicians (PCTs) were assigned to either remain in the room or use timers for rechecks.
- Compliance rates for blood glucose rechecks were measured for both groups.
Main Results:
- The timer intervention group showed significantly higher compliance (84%) compared to the room-stay group (52%).
- Timers allowed staff to manage other tasks while ensuring timely rechecks, unlike remaining in the patient's room.
- Overall hospital compliance with hypoglycemia rechecks reached 75% after timer implementation.
Conclusions:
- Timers are an effective and efficient tool for reminding hospital staff about post-hypoglycemia treatment blood glucose rechecks.
- This intervention addresses challenges faced by busy nursing staff in adhering to protocols.
- Implementing timers can improve overall adherence to critical patient safety protocols.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
SBAR II: Application of SBAR
6.2K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.2K
Insulin: Dosing Regimen and Adverse Effects
903
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
903
Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
721
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
721
Oral Hypoglycemic Agents: Glinides
747
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
747

